# Medical Oncology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sun Yat-sen (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET016-SYN
- Date: 2026-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Wen-Li Huang, MD
- Calendar frame: modern shifted

- To: Raymond Choi, MD, Medical Oncology
- Urgency: Within two weeks, with the CT and any biopsy result

## Referral question

A solid 6.8 cm mass in liver segments IV and V, inseparable from a gallbladder containing stones, in a 57-year-old man with three months of right upper abdominal aching, early fullness and 4 kg weight loss. He trained and briefly practiced as a physician. Multiphase CT, tumor markers and hepatitis serology are under way. Please establish the diagnosis, stage the disease, take him to the tumor board, and advise on treatment. **S**

## Questions for the consultant

1. Is this a primary liver cancer, a gallbladder or other biliary cancer, or a metastasis, and what tissue diagnosis is needed?
2. What further staging is needed, and is the tumor resectable?
3. How do his liver function and hepatitis B and C status affect the options?
4. What treatment do you advise, and how should it be planned with the multidisciplinary tumor board?
5. When should specialist palliative care join, and how should results be shared with a patient who is himself a physician?

## Pertinent history

Dull ache under the right ribs and early fullness for about three months; 4 kg weight loss; no jaundice, fever, itching or vomiting. Examination: a firm, non-tender mass 4 cm below the right costal margin; no ascites or nodes. Ultrasound today: a 6.8 cm solid, heterogeneous mass in segments IV and V that cannot be separated from the gallbladder, which contains stones; the rest of the liver smooth. Results today: hemoglobin 12.6 g/dL, platelets 342 x10^3/uL, creatinine 0.86 mg/dL, albumin 3.4 g/dL, bilirubin 0.9 mg/dL, alkaline phosphatase 212 U/L, AST 48 U/L, ALT 41 U/L, INR 1.0, alpha-fetoprotein 3.2 ng/mL, CA 19-9 412 U/mL, CEA 8.6 ng/mL. Hepatitis B and C serology sent. Never smoked; alcohol rarely. Acetaminophen as needed. No known allergies. ECOG 1. He leads a political organization and works full days. As a physician by training he asks to see his images and results, wants plain information, and wants to be cared for on the standard pathway. **S**

- Sun Yat-sen was born on November 12, 1866, into an ordinary farming family in Cuiheng Village. He was called Dixiang in childhood and also had the names Mingwen, Deming and Rixin; the name Yat-sen came into use while he was in Japan. **D**
- He went to a private school at nine, studied in Honolulu from the age of thirteen, and returned home at seventeen. **D**
- He began studying Western medicine at the Boji Hospital in Guangzhou in 1886 and in 1887 transferred to the College of Medicine for Chinese in Hong Kong, as one of its twelve students; his teachers included Patrick Manson. He was one of two students who passed the graduation examination in 1892 and received his diploma at the college's first graduation ceremony on July 23, 1892. **D**
- After graduating he practiced medicine in Macau, first at the Kiang Wu Hospital and then in a dispensary of his own, and then in Guangzhou, opening pharmacies that offered Chinese and Western medicines; about two years after graduating he gave up medicine for politics. **D**
- In 1894 he founded the China Revival Society in Honolulu; in 1905 he founded the Chinese Revolutionary League in Tokyo; on New Year's Day 1912 he became Provisional President of the Republic of China in Nanjing; and in January 1924 he presided over the First National Congress of the Kuomintang in Guangzhou. **D**

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

Baseline: White cells: 7.9 10*3/uL; Hemoglobin: 12.6 g/dL (low); Platelets: 342 10*3/uL; Sodium: 137 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.86 mg/dL; eGFR: 101 mL/min/1.73 m²; Glucose: 98 mg/dL; Albumin: 3.4 g/dL (low); Total bilirubin: 0.9 mg/dL; Alkaline phosphatase: 212 U/L (high); AST: 48 U/L (high); ALT: 41 U/L; INR: 1; Alpha-fetoprotein: 3.2 ng/mL; CA 19-9: 412 U/mL (high); CEA: 8.6 ng/mL (high); PHQ-2: 1; ECOG performance status: 1. All results are synthetic.

BP 132/84 mmHg; pulse 88 bpm; respirations 16/min; temperature 36.9 °C; oxygen saturation 98% on room air; weight 61 kg; BMI 22.4 kg/m². All vital signs are synthetic.

## Current medications

- Acetaminophen 500 mg oral tablet, two tablets by mouth every 8 hours as needed for right upper abdominal ache; no more than 3,000 mg a day **S**

## Plan so far

- Work-up of the liver mass: multiphase contrast CT of the liver with CT of the chest, abdomen and pelvis; MRI of the liver with MRCP if CT does not settle the origin; alpha-fetoprotein, CA 19-9 and CEA; hepatitis B surface antigen, core antibody and surface antibody, and hepatitis C antibody; liver function with Child-Pugh and ALBI scoring; and image-guided core biopsy, because a mass in a liver without cirrhosis cannot be diagnosed by imaging alone. Guideline: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026); AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma (2023) **S**
- Symptom care during the work-up: acetaminophen up to 3,000 mg a day, small frequent meals with a dietitian's advice, weight at every visit, and a same-day call for jaundice, fever, vomiting, dark urine or worse pain; results shared with him in full as they arrive, by one coordinating clinician. Guideline: NCCN Clinical Practice Guidelines in Oncology: Biliary Tract Cancers (2026) **S**
